Search Results

This flipbook provides basic information on active TB disease. The flipbook is in English and Marshallese. The resource can be used while working with patients and families from the Marshallese community.

This flipbook provides basic information on active TB disease. The resource can be used while working with patients and families from the Marshallese community.

WHO has published a global TB report every year since 1997. The main aim of the report is to provide a comprehensive and up-to-date assessment of the TB epidemic, and of progress in prevention, diagnosis and treatment of the disease at global, regional and country levels. This report is updated...

This toolkit is intended to assist health department viral hepatitis programs to assess viral hepatitis testing in laboratories operating in their jurisdictions.

The PrEP Cost Sharing Complaint Template is meant to assist providers and patients file a complaint about an uncompliant health plan charging for PrEP services.

The purpose of this toolkit is to help guide jurisdictions in organizing, supporting, and growing viral hepatitis coalitions that are community-oriented and effective in developing, implementing, and evaluating a viral hepatitis strategic plan.

This Guide focuses on common sexual concerns that can stand in the way of pleasure. It also provides practical solutions, tips on finding a professional who can help, and scripts for talking with a health care provider or therapist.

Developed by the coalition’s Communications Action Group, the Sexual Health Quick Tips provide easy-to-digest information and advice for the public. Using colorful graphics, they can be promoted via social media, including Instagram, Twitter, or Facebook.

This 2021 edition of Reported Tuberculosis in the United States reflects ongoing challenges facing the public health and tuberculosis (TB) communities. The report describes information on cases of TB disease reported to CDC since 1993. This year’s report emphasizes cases counted by the reporting...

This webinar built capacity on long-acting therapies, identified potential barriers to access, and discussed what is needed to prepare health systems to best absorb these technologies.